Tammy D. Vyas

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections”.

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections

JCI Insight(2021)10.1172/jci.insight.155483

N/A

0DataRank · unranked

57 citations

Julie Boucau, Rebecca F. Gilbert, Rockib Uddin, Jonathan Luu, Sebastien Haneuse +15 more

Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination

Clinical Infectious Diseases(2021)10.1093/cid/ciab643

N/A

0DataRank · unranked

33 citations

Amy K. Barczak, Robert H. Goldstein, Brian C. Healy, Dianne M. Finkelstein, Delaney D Ding +21 more

Duration of viral shedding and culture positivity with post-vaccination breakthrough delta variant infections

medRxiv(2021)10.1101/2021.10.14.21264747

N/A

0DataRank · unranked

5 citations

Julie Boucau, Rebecca F. Gilbert, Rockib Uddin, Jonathan Luu, Sebastien Haneuse +15 more

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant

JCI Insight(2022)10.1172/jci.insight.159944

N/A

0DataRank · unranked

30 citations

Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew +24 more

Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses

medRxiv(2022)10.1101/2022.03.02.22271731

N/A

0DataRank · unranked

23 citations

Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew +24 more

SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy

Annals of Internal Medicine(2023)10.7326/m23-1756

N/A

0DataRank · unranked

73 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency

medRxiv(2023)10.1101/2023.07.31.23293441

N/A

0DataRank · unranked

11 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

medRxiv(2023)10.1101/2023.06.23.23288598

N/A

0DataRank · unranked

5 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

Science Translational Medicine(2024)10.1126/scitranslmed.adk1599

N/A

0DataRank · unranked

98 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

Emerging SARS-CoV-2 Resistance After Antiviral Treatment

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.35431

N/A

0DataRank · unranked

45 citations

Manish C. Choudhary, Rinki Deo, Fizah Yousuf, A. Gomez, Gregory E. Edelstein +23 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.13.613000

N/A

0DataRank · unranked

2 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more

Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients

Research Square(2024)10.21203/rs.3.rs-5487774/v1

N/A

0DataRank · unranked

0 citations

Brooke M. Leeman, Patricia J. Botros, Joanna Folta, Dhiman Shahid, Anya I. Rocque +27 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

Journal of Virology(2025)10.1128/jvi.01623-24

N/A

0DataRank · unranked

18 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more

Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariants

JCI Insight(2025)10.1172/jci.insight.192228

N/A

0DataRank · unranked

1 citations

Owen T. Glover, Caitlin Marino, Gregory E. Edelstein, Manish C. Choudhary, Yijia Li +17 more

Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients

Vaccines(2025)10.3390/vaccines13090949

N/A

0DataRank · unranked

0 citations

Brooke M. Leeman, Patricia J. Botros, Joanna Folta, Dhiman Shahid, Anya I. Rocque +27 more